EP: 8 Rayner ASCRS 2023 Preview


Vice President of Marketing, Chris Willis, is joined by Marketing Director for the Americas, Sam van Roon, and Sr. Director and OMIDRIA Brand Lead, Nicolee Schulze to discuss what listeners can expect from Rayner at ASCRS this year, including the US launch of HASA OPTIX and RayPRO+, and new outcome data on Rayner products that will be presented on the podium.

Key Takeaways:

  • HASA OPTIX: Rayner is launching HASA OPTIX in the United States following a successful European launch. These instruments increase operating room efficiencies, save time and money, and improve inventory management. Surgeons can learn about HASA OPTIX at the Rayner booth, speak to the CEO, and test the quality of the instruments themselves.
  • RayPRO+: RayPRO+, an enhanced profile of RayPRO, also launches officially at ASCRS. RayPRO+ allows surgeons to collect and compare patient-reported outcomes from any IOL manufacturer, providing a brand agnostic platform. RayPRO+ offers insights into patient satisfaction, dysphotopsia rates, and target refraction; and it’s easier to use with a new CSV file technology. Roger Zaldivar will present new data on how RayPRO+ can deliver clinical data sets and insights without putting additional workload on staff.
  • Podium presentations: New data and outcomes with Rayner products will be shared in several podium presentations by KOLs (key opinion leaders). Dr. Michael Endl will be presenting a study comparing bilateral emmetropic outcomes with EMV to a standard monofocal. Other presentations will cover topics such as the effectiveness of OMIDRIA and the use of RayPRO to improve patient outcomes.